Login / Signup

Switching between GLP-1 receptor agonists in clinical practice: Expert consensus and practical guidance.

Akshay B JainAmar AliJuan José Gorgojo-MartínezIrene HramiakKetan KaviaSten MadsbadLouis PotierBen D ProhaskaJodi L StrongTina Vilsbøll
Published in: International journal of clinical practice (2020)
Switching from one GLP-1RA to another, such as OW semaglutide, can provide clinical benefits and may delay the need for treatment intensification.
Keyphrases
  • clinical practice
  • rheumatoid arthritis
  • disease activity
  • systemic lupus erythematosus
  • combination therapy
  • ankylosing spondylitis
  • replacement therapy
  • idiopathic pulmonary fibrosis